San Diego startup Hera Therapeutics is developing a topical antiviral drug that attacks human papillomavirus – and early studies are showing it can successfully combat three strains, including two that cause 70 percent of all cervical cancer. The drug candidate, HTI-1968, blocked the replication of HPV-16, HPV-18 and HPV-11 cells, according to the NIAID-sponsored study. The work […]
Under-the-radar San Diego startup Hera Therapeutics looks to be raising some early-stage capital to further its work in the antivirals space. The company, which is developing direct acting antivirals for human papilloma virus, human and animal retroviruses and herpes group viruses, filed regulatory paperwork to raise $1.3 million. It has thus far raised $1.1 million in […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.